France has taken a landmark step in its commitment to early access pathways for diagnostic innovation. On 5 June 2025, the Haute Autorité de Santé (HAS) published its first formal decision under the renewed …

As of April 2025, France’s Reimbursed Early Access Program (AAP, formerly ATU) continues to stand as one of Europe’s most advanced pathways for granting early, publicly funded access to life-saving therapies, even before full …

This weekend’s Independent ran a provocative headline:“Obese patients denied joint replacements in bid to slash NHS costs.” The story revealed that one-third of NHS Integrated Care Boards (ICBs) in England, and some in Wales, are …

Over the past decade, the European Economic Area (EEA) has seen a marked decline in its role as a hub for clinical trials. In 2013, approximately 22% of global industry-sponsored clinical trials …

The National Institute for Health and Care Excellence (NICE) recently published its HTE24 guidance under the Health Technology Evaluation (HTE) programme, marking a milestone for artificial intelligence in dermatology. At the centre of this evaluation is DERM, …

In an era defined by digital health transformation and data-driven care, Finland continues to lead in diagnostic interoperability, public reimbursement integration and laboratory standardisation. At the heart of this ecosystem lies a …

Rethinking Reimbursement: France’s Article 51 as a Model for Real-World Innovation In 2018, France introduced a powerful tool to reshape its health system from within: Article 51 of the Loi de Financement de la Sécurité …

In the two decades since the arrival of robotic-assisted surgery (RAS), clinical teams across urology, colorectal, gynaecological and orthopaedic domains have embraced its ergonomic advantages, precision tooling and potential for same-day recovery. …